Cognitive decline in a patient with anti-glutamic acid decarboxylase autoimmunity; case report

BACKGROUND: Glutamic acid decarboxylase (GAD) is the rate-limiting enzyme for producing γ-aminobutyric acid, and it has been suggested that antibodies against GAD play a role in neurological conditions and type 1 diabetes. However, it is not known whether dementia appears as the sole neurological ma...

Descripción completa

Detalles Bibliográficos
Autores principales: Takagi, Masahito, Yamasaki, Hiroshi, Endo, Keiko, Yamada, Tetsuya, Kaneko, Keizo, Oka, Yoshitomo, Mori, Etsuro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3292981/
https://www.ncbi.nlm.nih.gov/pubmed/22188660
http://dx.doi.org/10.1186/1471-2377-11-156

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3292981/
https://www.ncbi.nlm.nih.gov/pubmed/22188660
http://dx.doi.org/10.1186/1471-2377-11-156

Ejemplares similares